Prescription Required
Inclusive of all taxes
In Depression Sigpar Plus 12.5mg/0.5mg Tablet works by affecting the balance of certain chemicals (such as serotonin) in the brain. It helps improve mood and feelings of wellbeing, relieve anxiety and tension, helps you sleep better, and increase your energy level. It is an effective antidepressant but may cause drowsiness. You need to take it regularly as it is prescribed for it to be most effective and should not stop taking it suddenly.
It is unsafe to consume alcohol with Sigpar Plus 12.5mg/0.5mg Tablet.
Sigpar Plus 12.5mg/0.5mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Sigpar Plus 12.5mg/0.5mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Sigpar Plus 12.5mg/0.5mg Tablet may cause side effects which could affect your ability to drive.
Sigpar Plus 12.5mg/0.5mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Sigpar Plus 12.5mg/0.5mg Tablet may not be needed in these patients. Please consult your doctor. Use of Sigpar Plus 12.5mg/0.5mg Tablet can cause excessive sleepiness in patients with end stage kidney disease.
Sigpar Plus 12.5mg/0.5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Sigpar Plus 12.5mg/0.5mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Sigpar Plus 12.5mg/0.5mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Bioris Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Psycormedies || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Matteo Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Taswin Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Consern Pharma Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lifecare Neuro Products Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mitis Biomedics Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ipca Laboratories Ltd || ₹14.5/tablet (25% cheaper)